FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903842317> ?p ?o ?g. }

• W2903842317 endingPage "98" @default.
• W2903842317 startingPage "91" @default.
• W2903842317 abstract "Background: Impaired cognition and ambulation are common in multiple sclerosis (MS). Dalfampridine is the first Food and Drug Administration (FDA)–approved medication to treat impaired ambulation in MS. Dalfampridine may benefit patients with cognitive impairment, given its effects on saltatory conduction and the association between cognitive and motor function. Objective: To examine the effects of dalfampridine on cognition in MS. To determine if the anticipated improved cognition is grounded in dalfampridine’s effects on ambulation. Methods: Adults with MS were randomized to dalfampridine ( n = 45) or placebo ( n = 16) for 12 weeks. Cognition and motor function were assessed at baseline and end-point. Results: T25FW and 6-minute walk (6MW) performance improved at end-point in the treatment group but not in the placebo group ( p < 0.05). Our primary outcome, performance on the Symbol Digit Modalities Test, did not improve. About 30% ( n = 12) of the dalfampridine group demonstrated ⩾20% improved ambulation and were categorized “responders.” Among “responders”, Symbol Digit Modalities test performance did not improve. However, performance on the Paced Auditory Serial Addition Test improved among “responders” ( p < 0.05). Conclusion: Dalfampridine benefits timed ambulation but not cognition. Some improvement among ambulation “responders” is consistent with prior reports of cognition-motor coupling in MS ( ClinicalTrials.gov #: NCT02006160)." @default.
• W2903842317 created "2018-12-22" @default.
• W2903842317 creator A5007567092 @default.
• W2903842317 creator A5033147621 @default.
• W2903842317 creator A5052706697 @default.
• W2903842317 creator A5056204835 @default.
• W2903842317 creator A5074182254 @default.
• W2903842317 creator A5075596287 @default.
• W2903842317 creator A5080347094 @default.
• W2903842317 creator A5084437854 @default.
• W2903842317 creator A5088591117 @default.
• W2903842317 date "2018-12-19" @default.
• W2903842317 modified "2023-10-17" @default.
• W2903842317 title "Dalfampridine benefits ambulation but not cognition in multiple sclerosis" @default.
• W2903842317 cites W1980168320 @default.
• W2903842317 cites W2008120870 @default.
• W2903842317 cites W2013999515 @default.
• W2903842317 cites W2017381757 @default.
• W2903842317 cites W2036646790 @default.
• W2903842317 cites W2073306344 @default.
• W2903842317 cites W2084813602 @default.
• W2903842317 cites W2095552880 @default.
• W2903842317 cites W2107501599 @default.
• W2903842317 cites W2109818884 @default.
• W2903842317 cites W2114242035 @default.
• W2903842317 cites W2119705413 @default.
• W2903842317 cites W2121149730 @default.
• W2903842317 cites W2122545833 @default.
• W2903842317 cites W2134858140 @default.
• W2903842317 cites W2137424771 @default.
• W2903842317 cites W2137710256 @default.
• W2903842317 cites W2145583517 @default.
• W2903842317 cites W2149636184 @default.
• W2903842317 cites W2161634194 @default.
• W2903842317 cites W2167181885 @default.
• W2903842317 cites W2337053089 @default.
• W2903842317 cites W2415174635 @default.
• W2903842317 cites W2551011356 @default.
• W2903842317 cites W2588292672 @default.
• W2903842317 cites W2588488142 @default.
• W2903842317 cites W612998720 @default.
• W2903842317 doi "https://doi.org/10.1177/1352458518815795" @default.
• W2903842317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30566030" @default.
• W2903842317 hasPublicationYear "2018" @default.
• W2903842317 type Work @default.
• W2903842317 sameAs 2903842317 @default.
• W2903842317 citedByCount "15" @default.
• W2903842317 countsByYear W29038423172019 @default.
• W2903842317 countsByYear W29038423172020 @default.
• W2903842317 countsByYear W29038423172021 @default.
• W2903842317 countsByYear W29038423172022 @default.
• W2903842317 countsByYear W29038423172023 @default.
• W2903842317 crossrefType "journal-article" @default.
• W2903842317 hasAuthorship W2903842317A5007567092 @default.
• W2903842317 hasAuthorship W2903842317A5033147621 @default.
• W2903842317 hasAuthorship W2903842317A5052706697 @default.
• W2903842317 hasAuthorship W2903842317A5056204835 @default.
• W2903842317 hasAuthorship W2903842317A5074182254 @default.
• W2903842317 hasAuthorship W2903842317A5075596287 @default.
• W2903842317 hasAuthorship W2903842317A5080347094 @default.
• W2903842317 hasAuthorship W2903842317A5084437854 @default.
• W2903842317 hasAuthorship W2903842317A5088591117 @default.
• W2903842317 hasConcept C118552586 @default.
• W2903842317 hasConcept C142724271 @default.
• W2903842317 hasConcept C15744967 @default.
• W2903842317 hasConcept C169900460 @default.
• W2903842317 hasConcept C185711340 @default.
• W2903842317 hasConcept C1862650 @default.
• W2903842317 hasConcept C204787440 @default.
• W2903842317 hasConcept C27081682 @default.
• W2903842317 hasConcept C2777965283 @default.
• W2903842317 hasConcept C2780640218 @default.
• W2903842317 hasConcept C548259974 @default.
• W2903842317 hasConcept C71924100 @default.
• W2903842317 hasConcept C99508421 @default.
• W2903842317 hasConceptScore W2903842317C118552586 @default.
• W2903842317 hasConceptScore W2903842317C142724271 @default.
• W2903842317 hasConceptScore W2903842317C15744967 @default.
• W2903842317 hasConceptScore W2903842317C169900460 @default.
• W2903842317 hasConceptScore W2903842317C185711340 @default.
• W2903842317 hasConceptScore W2903842317C1862650 @default.
• W2903842317 hasConceptScore W2903842317C204787440 @default.
• W2903842317 hasConceptScore W2903842317C27081682 @default.
• W2903842317 hasConceptScore W2903842317C2777965283 @default.
• W2903842317 hasConceptScore W2903842317C2780640218 @default.
• W2903842317 hasConceptScore W2903842317C548259974 @default.
• W2903842317 hasConceptScore W2903842317C71924100 @default.
• W2903842317 hasConceptScore W2903842317C99508421 @default.
• W2903842317 hasFunder F4320315053 @default.
• W2903842317 hasIssue "1" @default.
• W2903842317 hasLocation W29038423171 @default.
• W2903842317 hasLocation W29038423172 @default.
• W2903842317 hasOpenAccess W2903842317 @default.
• W2903842317 hasPrimaryLocation W29038423171 @default.
• W2903842317 hasRelatedWork W1988808703 @default.
• W2903842317 hasRelatedWork W2040895039 @default.
• W2903842317 hasRelatedWork W2078502351 @default.
• W2903842317 hasRelatedWork W2173158125 @default.

• next